Health Care & Life Sciences » Pharmaceuticals | Cadila Healthcare Ltd.

Cadila Healthcare Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
70,600
84,971
92,523
92,727
117,489
Cost of Goods Sold (COGS) incl. D&A
41,977
49,194
48,836
55,640
68,843
Gross Income
28,623
35,777
43,687
37,087
48,646
SG&A Expense
19,879
22,158
24,564
22,148
26,258
EBIT
8,376
13,285
-
-
22,089
Unusual Expense
-
104
370
625
586
Non Operating Income/Expense
1,605
1,566
486
963
1,247
Interest Expense
902
679
528
631
1,108
Pretax Income
9,422
14,455
20,987
16,146
23,308
Income Tax
1,060
2,594
1,774
1,289
5,644
Equity in Affiliates
-
-
430
338
628
Consolidated Net Income
8,362
11,861
19,643
15,195
18,292
Net Income
8,036
11,485
19,339
14,904
17,946
Net Income After Extraordinaries
8,036
11,464
19,339
14,931
18,134
Net Income Available to Common
8,036
11,485
19,339
14,877
17,758
EPS (Basic)
7.85
11.24
18.89
14.53
17.35
Basic Shares Outstanding
1,024
1,024
1,024
1,024
1,024
EPS (Diluted)
7.85
11.24
18.89
14.53
17.35
Diluted Shares Outstanding
1,024
1,024
1,024
1,024
1,024
EBITDA
10,388
16,158
22,953
18,349
27,477
Other Operating Expense
368
334
909
323
299
Non-Operating Interest Income
343
387
627
573
494
Minority Interest Expense
326
376
304
291
346

About Cadila Healthcare

View Profile
Address
Zydus Tower
Ahmedabad Gujarat 380015
India
Employees -
Website http://www.zyduscadila.com
Updated 09/14/2018
Cadila Healthcare Ltd. operates as a pharmaceutical company, which engages in the discovery, development, and manufacture of healthcare therapies. The firm offer pharmaceutical products including India formulations, Zydus Generics, and medicines offered in other countries. The company was founded by Ramanbhai B.